Pan de cristal, Bread is life

Still waiting for the chick fil a vaccination drive thru

Liebe Entscheidungsträger, wie hoch sollen die Zahlen denn noch steigen bevor Ihr reagieren wollt??? Wir verpassen jede Ausfahrt zur Senkung der Zahlen. Unser Prognosemodell im Abgleich mit den realen Zahlen (in Grün) spricht Bände. Bitte handelt endlich!

Horrible refs don’t call fouls on Jokic. Malone complains and gets ejected. Time to stand up Denver Nuggets.

Facuuuu! Un, dos, tres Denver Nuggets

Did you know CBCI has completed 5000 Bone Marrow Transplants? Check out the story from Denver7 News here. thedenverchannel.com/news/local-new…

Some fresh baguettes for sunday

Did you know we're looking for a few good APPs? If you know any experienced BMT Physician Assistants or Nurse Practitioners, we would love to talk to them about joining our world-class team! ziprecruiter.com/job/5a9bc0b9

... and we have the lead

AUSTIN RIV3RS LET'S GOOO

The safety of our patients is paramount! hematology.org/newsroom/press…

We have specially-trained nurses ready to help you with any cancer questions and who can get you connected with the right resources. Call us at (844)482-4814. #askSARAH #CancerResources

⁦Mount Sinai Health System⁩ very interesting experience with patients post bi-specific relapse presented by Tarek Mouhieddine, MD at #ASH21 shows it appears possible to come back with a second T-cell redirecting agent #mmsm

Dr.Bachier’s IIT and first results on treatment for high risk Hodgkin's Lymphoma with nivolumab OPDIVO® (nivolumab) post ASCT is getting attention at Ash2021. Excellent work! Sarah Cannon Docs CBCI

My thoughts on the DETERMINATION trial in myeloma presented in the Plenary session of #ASCO22 and published simultaneously in NEJM #ASCO22VR 1) This is not a trial of transplant vs no transplant. 2) It's ~ the 5th RCT of early vs delayed transplant

3) As with prior RCTs it shows prolonged PFS with early transplant but similar overall survival. That's because transplant works, but the timing doesn't matter as far as survival is concerned. You do the same trial many times of course you are going to get the same results.

#Medtwitter friends: I've been having a blast on the BMT service with Chris Gibson and planning next week's #bmtsm #leusm teaching theme: 📰 Why we do what we do in allogeneic transplantation for myeloid malignancies: Classic/Pivotal trials/papers. Any you'd add/swap out?

ash.confex.com/ash/2022/webpr… Natalie Callander Binod Dhakal Plasma Cell Pete MASTER- Quadruplet induction, AHCT, MRD-adapted consolidation and treatment cessation... "the problem is that you stoped therapy in high risk"

Newly diagnosed with MM? MASTER-2 addressed response adapted therapy with the perspective of finite treatment. Accruing fast! #mmsm

Open now at CBCI!